Institution: Elpis Biopharmaceuticals

0:01:45

Research into multispecific and multifunctional cell therapy products

0:01:55

Developing the next generation of CAR-T cells

0:03:38

Insights into EPIM-001 for the treatment of hematological malignancies

0:02:01

Managing cytokine release syndrome during CAR-T cell therapy

0:02:12

Fully human anti-CD19 and CD22 bispecific tandem CAR-T